FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085448178> ?p ?o ?g. }

• W2085448178 endingPage "135" @default.
• W2085448178 startingPage "130" @default.
• W2085448178 abstract "A cabergolina é um agonista dopaminérgico e apresenta efeito de supressão sobre a prolactina. É usada para o tratamento de hiperprolactinemias em pacientes inférteis e na prevenção da síndrome da hiperestimulação ovariana nos ciclos de fertilização in vitro . Fazer revisão sistemática dos estudos que avaliaram a segurança do uso da cabergolina na embriogênese e na gestação. Revisão sistemática dos trabalhos publicados nos últimos 23 anos que relacionaram o uso de cabergolina no período gestacional com um possível efeito teratogênico. Esses estudos estavam disponíveis nas bases de dados científicas Medline, Lilacs e Scielo. Os descritores de busca usados foram cabergoline , pregnancy e teratogen . Foram selecionados 12 artigos publicados de 1994 a 2013. Verificou‐se a existência de cerca de 800 casos de gestantes expostas à cabergolina. A maioria dos artigos revisados demonstrou que a cabergolina é uma opção segura para o concepto e para a evolução da gestação. O uso não aumentou o risco de malformação fetal, aborto e parto prematuro. Os dados referentes ao uso da cabergolina durante a gravidez tornam‐se cada vez mais consistentes e grande parte dos artigos demonstra a confiabilidade e segurança desse medicamento. Cabergoline is a dopaminergic agonist and exhibits a suppression effect on prolactin. It is used to treat hyperprolactinemia in infertile patients and to prevent the ovarian hyperstimulation syndrome in vitro fertilization cycles. A systematic review on the literature looking for studies that evaluate the safety use of Cabergoline in the embryogenesis and in pregnancy. Systematic review of articles published in last 23 years that try to establish the relationship between the use of Cabergoline in the gestational period with a possible teratogenic effect. The papers were available in the following scientific databases: Medline, Lilacs e Scielo. The key words used were cabergoline, pregnancy and teratogen. Twelve articles published from 1994 to 2013 were selected. It has been found that 800 pregnant women were exposed to cabergoline. Most of the papers analysed showed that the cabergoline is a safety alternative for theconceptus and for the pregnancy outcome. Its use did not increase the risk of fetal malformation, miscarriage and premature birth. Data regarding the use of cabergoline during pregnancy have become increasingly consistent, and most articles have demonstrated the reliability and safety of this drug." @default.
• W2085448178 created "2016-06-24" @default.
• W2085448178 creator A5000423165 @default.
• W2085448178 creator A5011368850 @default.
• W2085448178 creator A5024550606 @default.
• W2085448178 creator A5031723329 @default.
• W2085448178 creator A5033891627 @default.
• W2085448178 creator A5039594522 @default.
• W2085448178 date "2014-09-01" @default.
• W2085448178 modified "2023-09-26" @default.
• W2085448178 title "Segurança do uso da cabergolina na embriogênese e na gestação" @default.
• W2085448178 cites W1963798736 @default.
• W2085448178 cites W1978900531 @default.
• W2085448178 cites W1979270155 @default.
• W2085448178 cites W1981151082 @default.
• W2085448178 cites W1990061063 @default.
• W2085448178 cites W1992388781 @default.
• W2085448178 cites W2009923883 @default.
• W2085448178 cites W2011561090 @default.
• W2085448178 cites W2017283375 @default.
• W2085448178 cites W2035952021 @default.
• W2085448178 cites W2037857613 @default.
• W2085448178 cites W2040892630 @default.
• W2085448178 cites W2050434570 @default.
• W2085448178 cites W2058731555 @default.
• W2085448178 cites W2059397575 @default.
• W2085448178 cites W2075361084 @default.
• W2085448178 cites W2081532357 @default.
• W2085448178 cites W2085215264 @default.
• W2085448178 cites W2102619243 @default.
• W2085448178 cites W2133109118 @default.
• W2085448178 cites W2160096955 @default.
• W2085448178 cites W46708427 @default.
• W2085448178 cites W1987455226 @default.
• W2085448178 doi "https://doi.org/10.1016/j.recli.2015.03.001" @default.
• W2085448178 hasPublicationYear "2014" @default.
• W2085448178 type Work @default.
• W2085448178 sameAs 2085448178 @default.
• W2085448178 citedByCount "0" @default.
• W2085448178 crossrefType "journal-article" @default.
• W2085448178 hasAuthorship W2085448178A5000423165 @default.
• W2085448178 hasAuthorship W2085448178A5011368850 @default.
• W2085448178 hasAuthorship W2085448178A5024550606 @default.
• W2085448178 hasAuthorship W2085448178A5031723329 @default.
• W2085448178 hasAuthorship W2085448178A5033891627 @default.
• W2085448178 hasAuthorship W2085448178A5039594522 @default.
• W2085448178 hasBestOaLocation W20854481781 @default.
• W2085448178 hasConcept C29456083 @default.
• W2085448178 hasConcept C71924100 @default.
• W2085448178 hasConceptScore W2085448178C29456083 @default.
• W2085448178 hasConceptScore W2085448178C71924100 @default.
• W2085448178 hasIssue "3" @default.
• W2085448178 hasLocation W20854481781 @default.
• W2085448178 hasOpenAccess W2085448178 @default.
• W2085448178 hasPrimaryLocation W20854481781 @default.
• W2085448178 hasVolume "29" @default.
• W2085448178 isParatext "false" @default.
• W2085448178 isRetracted "false" @default.
• W2085448178 magId "2085448178" @default.
• W2085448178 workType "article" @default.